NASDAQ
No price data available for this timeframe.
Corcept Therapeutics Incorporated (CORT) has a revenue compound annual growth rate of 16.56% over 5 years and 31.23% over 10 years. Revenue CAGR shows the compound annual growth rate of a company's total sales, indicating the pace of top-line expansion.